BioStrand Omics Analysis Blog

Our omics analysis blog brings insights into genetics and genomics research solutions, and their leading role in the development of this industry.

Efficient data integration is the key to effective AI/ML

Dr Ingrid Brands, CEO | May 18, 2022

AI/ML technologies can be notoriously data-hungry with the broader concern being that certain...

Attention Mechanisms, Transformers and NLP

Dr Ingrid Brands, CEO | May 12, 2022

Natural Language Processing is a multidisciplinary field and over the years several models and...

Data related challenges in NLP

Dr Ingrid Brands, CEO | May 4, 2022

NLP challenges can be classified into two broad categories. The first category is linguistic and...

The BioStrand Interviews: Meet Thijs van Ulden

BioStrand | April 27, 2022

Thijs is a man of many parts. As a self-taught technology professional, he has worked with more...

Knowledge Graphs & The Power Of Context

Dr Ingrid Brands, CEO | April 20, 2022

Data overload is becoming a real challenge for businesses of all stripes even as a majority...

Subscribe to our blog

AI, ML, DL, and NLP: An Overview

Dr Ingrid Brands, CEO | April 13, 2022

Today artificial intelligence (AI), machine learning (ML), deep learning (DL) and natural language...

Why Is NLP Challenging?

Dr Ingrid Brands, CEO | April 6, 2022

A 2021 Natural Language Processing (NLP) industry survey found a significant year-on-year increase...

AI in drug development - towards fully autonomous drug discovery

Dr Ingrid Brands, CEO | March 30, 2022

In our previous blog, we noted how the increasing utilization of AI across different phases of the...

The BioStrand Interviews: Meet Christophe Van Neste

BioStrand | March 23, 2022

Bioengineer, philosopher, programmer, bioinformatician and teacher, Christophe Van Neste is a truly...

AI in drug development - from hype to reality

Dr Ingrid Brands, CEO | March 16, 2022

Back in 1981, a Discovery magazine article called Designing Drugs With Computers detailed a...

The importance of NLP in biomedical research

Dr Ingrid Brands, CEO | March 9, 2022

There will be more than twice as much digital data created over the next five years as has been...